Apo AI increased significantly in both groups and the differences were 53.964.3 in the EGCG group and 31.358.7 in the placebo group
GLP-1 receptor agonists are medications that mimic this hormone, helping to reduce hunger, slow gastric emptying, and improve insulin sensitivity
Translation into broad tobacco-control practice will definitely hinge on durability of abstinence effects, tolerability, cost, and access, so policy should prioritize targeted implementation and definitive pragmatic trials rather than immediate guideline expansion
GLP-1s are being studied for potential cognitive benefits and use in addiction treatment
(PubMed) Weston SB, Zhou S, Weatherby RP, Robson SJ